Sun, Jan 25, 2015, 8:45 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • blackoutbuzz blackoutbuzz Oct 24, 2013 9:08 AM Flag

    Earnings out

    Bingo... back to solid growth again

    @@@@@British drugmaker Shire raised its full-year earnings growth forecast on Thursday after lower-than-expected research and development costs helped it to beat forecasts for the third quarter. The company, which makes drugs to treat hyperactivity and expensive medicines for rare disease, reported a 12 percent rise in revenue to $1.24 billion and earnings measured in non-GAAP EPS per ADS of $1.77, up 30 percent. Analysts were expecting the company to report revenue of $1.2 billion and non-GAAP EPS per ADS of $1.63, according to a company-compiled poll of 20 brokers. It said it now expected to deliver mid-to-high teens growth in Non GAAP earnings for 2013, up from double-digit growth it predicted in July. Shares in Shire, which have risen by a third since the start of the year, hitting an all-time of 2,602 pence last month, extended earlier gains to trade up 5 percent at 2,655 pence at 1112 GMT on Thursday.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Looks like that $142 prices target could be justified with results like these.

      Product sales +13% - with eight of our products delivering double digit growth in the quarter - including VYVANSE® (+21%), LIALDA®/MEZAVANT® (+36%) and FIRAZYR®(+107%)
      Non GAAP operating income +30% reflecting strong operating leverage
      Non GAAP earnings per ADS +30%
      Non GAAP cash generation +36%
      Guidance increased to mid-to-high teens Non GAAP earnings growth for the full year in 2013

216.03+2.27(+1.06%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.